Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT03329690
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]
233
Enrollment(s)
66
Study location(s)
Interventional (Phase II)
Neoplasm, Gastrointestinal
Recruiting
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
16,000
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Terminated
NCT01452152
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
9
Enrollment(s)
5
Study location(s)
Interventional (Phase IV)
Cardiovascular Diseases
Acute Coronary Syndrome
Active, not recruiting
NCT04112589
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
63
Enrollment(s)
20
Study location(s)
Interventional (Phase I|Phase II)
Acute Myeloid Leukemia
Completed
NCT04471870
ARCANGELO (itAlian pRospective Study on CANGrELOr)
1,005
Enrollment(s)
30
Study location(s)
Observational
Acute Coronary Syndrome
Completed
NCT05247385
Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel
87
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
대상자 모집 전
KCT0006700
비파열성 대뇌동맥류의 스텐트 혹은 혈류 전환기 치료에서 저용량 프라수그렐 대 클로피도그렐의 비교: 다기관 무작위 배정 연구
406
Enrollment(s)
1
Study location(s)
관찰연구 (None)
Completed
NCT00652327
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
83
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Hypercholesterolemia
46
47
48
49
50